Search
Triethylene glycol
go.drugbank.com/drugs/DB02327ExperimentalCategories: Compounds used in a research, industrial, or household settingTricaprylin
go.drugbank.com/drugs/DB12176InvestigationalTricaprilin has been used in trials studying the supportive care and treatment of Alzheimer's Disease.
Categories: Compounds used in a research, industrial, or household settingTrimethyltetradecylammonium
go.drugbank.com/drugs/DB17342ExperimentalSynonyms: Tetradonium ion, 1-tetradecanaminium, n,n,n-trimethyl-Categories: Compounds used in a research, industrial, or household settingAminoethyl nitrate
go.drugbank.com/drugs/DB13585ExperimentalCategories: Vasodilators Used in Cardiac Diseases3,4-Dihydroxycinnamic Acid
go.drugbank.com/drugs/DB01880InvestigationalCategories: Compounds used in a research, industrial, or household settingAcrihellin
go.drugbank.com/drugs/DB21069ExperimentalAcrihellin is a small molecule drug. Acrihellin has a monoisotopic molecular weight of 498.26 Da.
Categories: Compounds used in a research, industrial, or household settingGusperimus
go.drugbank.com/drugs/DB12692InvestigationalGusperimus has been used in trials studying the treatment of Lupus Nephritis, Wegeners Granulomatosis, and Wegener's Granulomatosis.
Categories: Compounds used in a research, industrial, or household settingGataparsen
go.drugbank.com/drugs/DB05141InvestigationalLY2181308 is investigated in clinical trials for treating solid tumors. LY2181308 is a solid. LY2181308 is directed against a molecular target called survivin. … LY2181308 is an anti-sense oligonucleotide that potently downregulated survivin expression in human cancer cells derived from lung, colon, breast, prostate, ovary, cervix, skin and brain.
Chlorambucil
go.drugbank.com/drugs/DB00291ApprovedInvestigationalAlthough it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
Synonyms: N,N-di-2-chloroethyl-γ-p-aminophenylbutyric acid, N,N-di-2-chloroethyl-gamma-p-aminophenylbutyric acidILY101
go.drugbank.com/drugs/DB05059InvestigationalILY101 is designed to allow for lower daily doses and improved patient acceptance and tolerability in comparison to other products in this class of drugs. … ILY101 is being developed for the treatment of hyperphosphatemia in CKD patients on dialysis and works by reducing the systemic absorption of dietary phosphate.